microRNA-7: A tumor suppressor miRNA with therapeutic potential

MiReven scientists have published a review on Micro RNA-7 in the June 2014 edition of The International Journal of Biochemistry & Cell Biology.  The article, entitled “microRNA-7: A tumor suppressor miRNA with therapeutic potential“, is part of a Directed Issue of the Journal entitled, “The Non-coding RNA Revolution”. The co-authors of the article feature miReven scientific founders Felicity […]

MiReven Receives United States Patent

Perth, Western Australia (30 April, 2014)  MiReven Pty Ltd (mireven.com.au), an Australian microRNA company commercialising discoveries from the Harry Perkins Institute of Medical Research on the anti-cancer potential of miR-7, announces today the grant of its first patent by the United States Patent Office. The granted US patent, ‘Method Of Modulation of Expression of Epidermal […]